Fabien Guillemot

Papers

Total Citations

282

H-Index

About

Fabien Guillemot is a pioneering figure in the field of bioprinting, with a specific focus on laser-assisted technologies for in vivo and in situ tissue engineering. His research centers on developing computer- and robotic-assisted medical interventions that enable the direct printing of biological materials within living organisms. Guillemot’s most notable contribution is his groundbreaking 2010 study, which presented the first attempt to apply bioprinting in a clinical context, demonstrating the printing of nano-hydroxyapatite directly into a mouse calvaria defect model. This work, which has garnered 275 citations, established a foundational proof-of-concept for in vivo bioprinting, paving the way for future applications in bone regeneration and surgical repair. His 2015 paper further advanced the field by detailing laser-assisted bioprinting techniques for in situ biofabrication. Guillemot’s work is characterized by its interdisciplinary approach, merging engineering, biology, and medicine to create innovative solutions for tissue repair. His achievements have positioned him as a key innovator in the rapidly evolving field of bioprinting, inspiring new avenues for regenerative medicine and personalized surgical interventions.